GATA-3 Identifies a Distinct Subset of T-PLL Associated with Skin Involvement and CCR4 Expression
Marc Gutierrez, Chenguang Wang, Kedar Inamdar, Michael B. Stone et autres
0 citationsBlood Neoplasia
Ryan A. Wilcox
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
302Publications signalées
8195Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchCutaneous lymphoproliferative disorders researchT-cell and Retrovirus StudiesImmune Cell Function and Interaction
Publications récentes
Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas
Richard A. Miller, Ning Ding, John Reneau, Yuqin Song et autres
0 citationsBlood
A single-cell atlas identifies oncogenic transcriptional programs and immune escape mechanisms in CTCL
Chenguang Wang, Xiangrong Geng, Suhaib Abdelrahman, You Fu et autres
0 citationsBlood
Gene expression profiling reveals 2 overarching types of ALCL with distinct targetable biology: an LLMPP study
Andrew L. Feldman, Surendra Dasari, Lisa M. Rimsza, David W. Scott et autres
7 citationsBlood
CDK9 is a dependency in GATA-3 driven and MCL-1 independent T-cell Lymphomas
Chenguang Wang, Suhaib Abdelrahman, Xiangrong Geng, Alyssa Burgess et autres
1 citationBlood Cancer Journal
Allogeneic stem cell transplant results in t-cell prolymphocytic leukemia (T-PLL): A collaborative multi-center study cohort
Zachary Braunstein, Eric McLaughlin, Prasanth Lingamaneni, Stefan K. Barta et autres
0 citationsBlood
Final results of a phase 1 trial with soquelitinib (SQL), a selective interleukin-2-inducible T cell kinase (ITK) inhibitor for treatment of relapsed/refractory (R/R) T cell lymphomas (TCL)
Richard A. Miller, Ryan A. Wilcox, John Reneau, Costas K. Yannakou et autres
2 citationsBlood
More than skin deep
0 citationsBlood
A Phase 1a/1b Trial in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma to Determine the Safety Profile, Pharmacology, and Maximum Tolerated Dose of ST-001, an Intravenous Fenretinide Phospholipid Suspension (12.5 mg/mL)
Oleg E. Akilov, Auris Huen, Barbara Pro, Dipenkumar Modi et autres
0 citationsEuropean Journal of Cancer
Transcriptional Analysis of Effusion-Based Lymphoma Supports a Post-Germinal Center Origin and Specific Inflammatory Signal Background
Vanessa Pérez‐Silos, Hojung Kim, Chenguang Wang, Alejandro Zevallos-Morales et autres
0 citationsCancers
Mycosis Fungoides, Sézary Syndrome, and Cutaneous B‐Cell Lymphomas: 2025 Update on Diagnosis, Risk‐Stratification, and Management
Alexandra C. Hristov, Trilokraj Tejasvi, Ryan A. Wilcox
16 citationsAmerican Journal of Hematology
135 | LONG‐TERM FOLLOW UP OF THE VALOR (VENETOCLAX, LENALIDOMIDE, RITUXIMAB) IN PATIENTS W/ UNTREATED MANTLE CELL LYMPHOMA
Tycel Phillips, Jonathan M. Weiss, David A. Bond, Lizhi Xiao et autres
2 citationsHematological Oncology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.